Australia's LTR Pharma hits over a month high on US distribution deal
09/06/2026 04:02
BUZZ-Australia's LTR Pharma hits over a month high on US distribution deal ** Shares of Australia's LTR Pharma LTP.AX rise as much as 16.1% to A$0.54, its highest level since May 1
** Stock on track for a third consecutive session of gains if the current trend holds
** The clinical-stage biopharma co says it signs binding agreement with US-based direct-to-consumer (DTC) telehealth platform, Shed Holdings, to distribute ROXUS in the US
** ROXUS is the company's oral drug treatment for erectile dysfunction
** Despite moves, stock down 34.7% YTD
(Reporting by Aamir Sheik Khalid in Bengaluru)
Recent news on Ltr Pharma
See all newsAustralia's LTR Pharma surges as its drug begins US prescription fulfillment
Brief: LTR Pharma Executes Exclusive Pilot Agreement With Marius Pharmaceuticals, Inc For Kyzatrex
Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
Australia's LTR Pharma rises on commercial tie-up with US telehealth firm
Australia's LT Pharma gains after nod to test nasal spray